Search This Blog

Monday, May 11, 2026

Erasca, Merck enter Keytruda supply pact for AURORAS-1 trial of ERAS-0015 in RAS-mutant solid tumors

 

Erasca, Merck enter Keytruda supply collaboration for AURORAS-1 trial of ERAS-0015 in RAS-mutant solid tumors

  • Merck will provide pembrolizumab (Keytruda) for AURORAS-1 proof-of-concept study evaluating ERAS-0015 plus pembrolizumab in RAS-mutant solid tumors.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)